V. A. Stewart

发表

On the future of automated selective asparagus harvesting technology

G. Arndt, R. Rudziejewski, V. A. Stewart, 1997 .

THE USE OF 3D SIMULATION IN THE DEVELOPMENT OF NEW TOOLING AND TOOL GRINDING PROCESSES

V. A. Stewart, 1999 .

Enzyme-Linked Immunosorbent Assay for Detection of Plasmodium falciparum Histidine-Rich Protein 2 in Blood, Plasma, and Serum

V. A. Stewart, David J. Sullivan, D. Sullivan, 2008, Clinical and Vaccine Immunology.

Malaria diagnostics in clinical trials.

V. A. Stewart, Sean C. Murphy, S. Parikh, 2013, The American journal of tropical medicine and hygiene.

Malaria diagnostics in clinical trials.

V. A. Stewart, S. Parikh, S. Murphy, 2013, The American journal of tropical medicine and hygiene.

Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen.

V. A. Stewart, M. Demoitié, Joe D. Cohen, 2008, Vaccine.

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.

V. A. Stewart, Janet Wittes, J. Wittes, 2007, Vaccine.

Safety and Allele-Specific Immunogenicity of a Malaria Vaccine in Malian Adults: Results of a Phase I Randomized Trial

V. A. Stewart, A. Dicko, O. Doumbo, 2006, PLoS clinical trials.

EVALUATION OF PERFORMANCE OF TWO MONOPLEX QUANTITATIVE REAL TIME PCR ASSAYS IN COMPARISON TO MICROSCOPY FOR IDENTIFICATION OF MALARIA PARASITES.

V. A. Stewart, Clifford Ogweno Obuya, Amolo Stephen Asito, 2022, PARIPEX-INDIAN JOURNAL OF RESEARCH.

Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice.

V. A. Stewart, M. Demoitié, Joe D. Cohen, 2008, Vaccine.

Priming with an Adenovirus 35-Circumsporozoite Protein (CS) Vaccine followed by RTS,S/AS01B Boosting Significantly Improves Immunogenicity to Plasmodium falciparum CS Compared to That with Either Malaria Vaccine Alone

V. A. Stewart, M. Demoitié, Joe D. Cohen, 2007, Infection and Immunity.

Status of malaria vaccine R&D in 2007

V. A. Stewart, D. Doolan, 2007, Expert review of vaccines.

Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.

V. A. Stewart, Joe D. Cohen, S. Pichyangkul, 2006, Vaccine.

HIV-1 Impact on Malaria Transmission: A Complex and Relevant Global Health Concern

V. A. Stewart, S. Luckhart, Emily Ferraro, 2021, Frontiers in Cellular and Infection Microbiology.

Longitudinal impact of asymptomatic malaria/HIV-1 co-infection on Plasmodium falciparum gametocyte transcript expression and transmission to Anopheles mosquitoes

V. A. Stewart, S. Luckhart, Carolyne M. Kifude, 2022, Frontiers in Cellular and Infection Microbiology.

Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study

V. A. Stewart, J. Vulule, A. Moormann, 2016, PloS one.

Receptor 9-Dependent Pathway Murine Dendritic Cells through a Toll-Like Human Plasmacytoid Dendritic Cells and Malaria Blood Stage Parasites Activate

V. A. Stewart, S. Akira, Rebecca S Miller, 2004 .

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

V. A. Stewart, J. Wittes, M. Thera, 2005, Vaccine.

Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.

V. A. Stewart, M. Fukuda, E. Bergmann-Leitner, 2009, Vaccine.

Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

V. A. Stewart, S. D. de Vlas, Joe D. Cohen, 2009, PloS one.

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.

V. A. Stewart, J. Haynes, Joe D. Cohen, 2007, Vaccine.

Activation of Innate Immunity in Healthy Macaca mulatta Macaques by a Single Subcutaneous Dose of GMP CpG 7909: Safety Data and Interferon-Inducible Protein-10 Kinetics for Humans and Macaques

V. A. Stewart, E. Angov, A. Krieg, 2007, Clinical and Vaccine Immunology.

Isolation and characterization of rhesus blood dendritic cells using flow cytometry.

V. A. Stewart, S. Pichyangkul, W. Ballou, 2001, JIM - Journal of Immunological Methods.

Quality and Integrated Service Delivery: A Cross-Sectional Study of the Effects of Malaria and Antenatal Service Quality on Malaria Intervention Use in Sub-Saharan Africa

V. A. Stewart, T. Koehlmoos, J. Bennett, 2022, Tropical medicine and infectious disease.

Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya

V. A. Stewart, W. Ripley Ballou, Janet Wittes, 2009, PloS one.

Effects of Preexposure to DEET on the Downstream Blood-Feeding Behaviors of Aedes aegypti (Diptera: Culicidae) Mosquitoes

V. A. Stewart, M. Turell, C. Olsen, 2016, Journal of Medical Entomology.

Dengue Virus-1 Infection Did Not Alter the Behavioral Response of Aedes aegypti (Diptera: Culicidae) to DEET

V. A. Stewart, M. Turell, C. Olsen, 2016, Journal of Medical Entomology.

Coccidia of the llama, Lama glama, in Colorado and Wyoming.

V. A. Stewart, W. C. Marquardt, T. A. Abbott, 1991, Veterinary parasitology.

A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and explore apical membrane antigen 1 diversity

V. A. Stewart, Steve M. Taylor, J. Bailey, 2017, Malaria Journal.

Characterization of Plasmodium ovale curtisi and P. ovale wallikeri in Western Kenya Utilizing a Novel Species-specific Real-time PCR Assay

V. A. Stewart, B. Ogutu, S. Luckhart, 2015, PLoS neglected tropical diseases.

HIV-1 Infection Is Associated With Increased Prevalence and Abundance of Plasmodium falciparum Gametocyte-Specific Transcripts in Asymptomatic Adults in Western Kenya

V. A. Stewart, S. Luckhart, D. Rockabrand, 2021, Frontiers in Cellular and Infection Microbiology.

Initiation of anti-retroviral/Trimethoprim-Sulfamethoxazole therapy in a longitudinal cohort of HIV-1 positive individuals in Western Kenya rapidly decreases asymptomatic malarial parasitemia

V. A. Stewart, S. Luckhart, Carolyne M. Kifude, 2022, Frontiers in Cellular and Infection Microbiology.

Plasmodium falciparum DHFR and DHPS Mutations Are Associated With HIV-1 Co-Infection and a Novel DHPS Mutation I504T Is Identified in Western Kenya

James T. Van Leuven, V. A. Stewart, Brandi K. Torrevillas, 2020, Frontiers in Cellular and Infection Microbiology.

Longitudinal and Cross-sectional Analyses of Asymptomatic HIV-1/Malaria Co-infection in Kisumu County, Kenya.

V. A. Stewart, S. Luckhart, Carolyne M. Kifude, 2022, The American journal of tropical medicine and hygiene.

Asymptomatic falciparum and Non-falciparum Malarial Parasitemia in Adult Volunteers with and without HIV-1 Coinfection in a Cohort Study in Western Kenya.

V. A. Stewart, Brandi K. Torrevillas, S. Luckhart, 2021, The American journal of tropical medicine and hygiene.

Immune mechanisms in malaria: new insights in vaccine development

V. A. Stewart, E. Riley, Eleanor M Riley, 2013, Nature Medicine.

Distribution of Triatoma dimidiata sensu lato (Reduviidae: Triatominae) and Risk Factors Associated with Household Invasion in Northern Belize, Central America

V. A. Stewart, Angela T Caranci, P. Masuoka, 2022, Journal of Medical Entomology.

Chemoprophylactic effects of milbemycin oxime against larvae of Dirofilaria immitis during prepatent development.

V. A. Stewart, D. Hepler, J. Parsons, 1991, American journal of veterinary research.

Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands

V. A. Stewart, A. Githeko, Guofa Zhou, 2012, BMC Infectious Diseases.

Malaria Blood Stage Parasites Activate Human Plasmacytoid Dendritic Cells and Murine Dendritic Cells through a Toll-Like Receptor 9-Dependent Pathway1

V. A. Stewart, S. Akira, S. Pichyangkul, 2004, The Journal of Immunology.

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.

V. A. Stewart, W. Ballou, Joe D. Cohen, 2009, The Journal of infectious diseases.

Using Hematology Data from Malaria Vaccine Research Trials in Humans and Rhesus Macaques (Macaca mulatta) To Guide Volume Limits for Blood Withdrawal.

V. A. Stewart, S. Mcgrath, S. Hegge, 2016, Comparative medicine.

A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and explore apical membrane antigen 1 diversity

V. A. Stewart, J. Bailey, S. Meshnick, 2017, Malaria Journal.

Plasmodium vivax under the microscope: the Aotus model.

V. A. Stewart, 2003, Trends in parasitology.

Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques.

V. A. Stewart, Joe D. Cohen, K. Kester, 2006, Vaccine.

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial

V. A. Stewart, A. Dicko, O. Doumbo, 2008, PloS one.

Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan Children

V. A. Stewart, J. Wittes, B. Ogutu, 2006, PLoS clinical trials.

Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.

V. A. Stewart, Joe D. Cohen, A. Hess, 2006, Vaccine.

Characterization of a human reference standard for antibody to Plasmodium falciparum merozoite surface protein 1(42).

V. A. Stewart, E. Angov, I. Yoon, 2005, The American journal of tropical medicine and hygiene.

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.

V. A. Stewart, Marie-Claude Dubois, In-Kyu Yoon, 2010, Vaccine.

Preclinical Evaluation of the Safety and Immunogenicity of a Vaccine Consisting of Plasmodium falciparum Liver-Stage Antigen 1 with Adjuvant AS01B Administered Alone or Concurrently with the RTS,S/AS01B Vaccine in Rhesus Primates

V. A. Stewart, Joe D. Cohen, M. Fukuda, 2007, Infection and Immunity.

Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor–Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)

V. A. Stewart, R. Schooley, F. Ssali, 2021, Journal of acquired immune deficiency syndromes.

Distribution of Triatoma dimidiata sensu lato (Reduviidae: Triatominae) and Risk Factors Associated with Household Invasion in Northern Belize, Central America

V. A. Stewart, P. Masuoka, J. Grieco, 2022, Journal of medical entomology.

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

V. A. Stewart, J. Wittes, M. Thera, 2005, Vaccine.